ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $340,000 | +7.3% | 82,877 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $317,000 | -4.8% | 88,710 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $333,000 | -18.4% | 91,365 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $408,000 | +3.6% | 93,535 | -2.4% | 0.00% | 0.0% |
| Q1 2021 | $394,000 | +3.4% | 95,790 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $381,000 | +43.8% | 95,537 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $265,000 | -4.0% | 98,279 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $276,000 | +22.1% | 100,513 | +5.0% | 0.00% | 0.0% |
| Q1 2020 | $226,000 | -52.5% | 95,744 | -5.5% | 0.00% | -50.0% |
| Q4 2019 | $476,000 | +39.2% | 101,276 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $342,000 | +1.2% | 102,128 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $338,000 | +21.1% | 102,840 | +11.7% | 0.00% | 0.0% |
| Q1 2019 | $279,000 | +7.7% | 92,061 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $259,000 | -19.6% | 95,044 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $322,000 | +32.5% | 95,776 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $243,000 | +20.3% | 94,049 | +2.4% | 0.00% | 0.0% |
| Q1 2018 | $202,000 | +4.7% | 91,853 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $193,000 | -38.1% | 96,793 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $312,000 | +8.7% | 96,335 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $287,000 | -99.6% | 89,132 | -1.7% | 0.00% | – |
| Q1 2016 | $79,000,000 | -28.2% | 90,637 | 0.0% | 0.00% | – |
| Q4 2015 | $110,000,000 | +71328.6% | 90,637 | -0.2% | 0.00% | -100.0% |
| Q3 2015 | $154,000 | -99.9% | 90,794 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $188,627,000 | -5.2% | 90,686 | +23.5% | 0.00% | 0.0% |
| Q1 2015 | $198,919,000 | +5.4% | 73,402 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $188,643,000 | +35.1% | 73,402 | -3.8% | 0.00% | 0.0% |
| Q3 2014 | $139,642,000 | -31.5% | 76,307 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $203,889,000 | -24.3% | 76,363 | -0.7% | 0.00% | 0.0% |
| Q1 2014 | $269,161,000 | -20.0% | 76,903 | +2.5% | 0.00% | -50.0% |
| Q4 2013 | $336,276,000 | +9.6% | 75,062 | -0.7% | 0.00% | 0.0% |
| Q3 2013 | $306,790,000 | +0.1% | 75,564 | +2.6% | 0.00% | 0.0% |
| Q2 2013 | $306,446,000 | – | 73,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |